Phathom Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference
Phathom Pharmaceuticals (Nasdaq: PHAT) announced its management team's participation in the 21st Annual Needham Virtual Healthcare Conference on April 12, 2022, at 9:30 a.m. ET. The conference runs from April 11-14, 2022, during which the company will also hold one-on-one meetings. Investors can access the live webcast and recordings for 90 days via the Phathom website. The company focuses on developing treatments for gastrointestinal diseases, particularly vonoprazan, a potassium competitive acid blocker in late-stage development for acid-related disorders.
- None.
- None.
FLORHAM PARK, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that members of the management team will participate in a fireside chat at the 21st Annual Needham Virtual Healthcare Conference on Tuesday, April 12, 2022 at 9:30 a.m. ET.
Company management will also participate in one-on-one meetings during the virtual conference which runs from April 11-14, 2022.
To access the live webcast and archived recording of the presentation, visit the News & Events section of the Phathom website at https://investors.phathompharma.com/news-events/events-and-presentations. The recording will be available for 90 days following the event.
About Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases and disorders. Phathom has in-licensed the exclusive rights in the United States, Europe, and Canada to vonoprazan, a novel potassium competitive acid blocker (P-CAB) in late-stage development for the treatment of acid-related disorders. For more information about Phathom, visit the Company’s website at http://www.phathompharma.com and follow the Company on LinkedIn and Twitter.
CONTACTS
Media Contact:
Nick Benedetto
1-877-742-8466
media@phathompharma.com
Investor Contact:
Joe Hand
1-877-742-8466
ir@phathompharma.com
FAQ
When is Phathom Pharmaceuticals participating in the Needham Virtual Healthcare Conference?
What is the focus of Phathom Pharmaceuticals?
What product is Phathom Pharmaceuticals developing?
How long will the webcast of the Phathom presentation be available?
What dates does the Needham Virtual Healthcare Conference run?
